siRNA therapy reduces triglycerides in individuals with uncommon problem

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels through 80% as well as reduced the risk of pancreatitis in clients along with consistent chylomicronemia, with or even without a genetic diagnosis.